Literature DB >> 12404654

The clock drawing test and questionable dementia: reliability and validity.

Eva Seigerschmidt1, Edelgard Mösch, Margarete Siemen, Hans Förstl, Horst Bickel.   

Abstract

OBJECTIVES: In order to evaluate the suitability of the clock drawing test (CDT) for the detection of questionable dementia (QD), we assessed the inter-rater reliabilities and intercorrelations of four common scoring methods of the CDT in a sample of non-demented subjects and determined the concurrent validity.
METHODS: The study sample consisted of 253 discharged general hospital patients, aged between 65 and 85 years. Subjects were screened for cognitive impairment during their hospital stay. Four to six weeks after discharge each non-demented patient was visited at home and interviewed by a trained psychologist. The interview procedure included a cognitive test battery incorporating the CDT, the Mini-Mental State Examination (MMSE), the Syndrome Short Test (SKT), and a verbal fluency test (VF). The criteria of the Clinical Dementia Rating (CDR) were used to differentiate between cognitively normal subjects and those with QD. Clock drawings were scored independently and blindly by two raters according to four different methods. The agreement between raters was assessed, as well as the agreement between the different scoring methods. The association of gender, education, age, test performance and CDR-rating with CDT scores was examined. Accuracy of the CDT for the detection of QD was calculated.
RESULTS: Inter-rater reliabilities were high for all four scoring methods. However, substantial differences among the scoring methods were observed, the proportion of abnormal test results varying between 9% and 50%. The CDT correlated significantly with MMSE, SKT and VF, but correlation coefficients were low (r = 0.13 to r = 0.32). Furthermore, CDT scores were influenced by age, gender, and education. Sensitivity of the CDT for QD was 66%, specificity was 65%; the negative predictive value was 73%, the positive predictive value 58%.
CONCLUSION: In a sample of non-demented elderly, the reliability of the CDT was sufficiently high, but the different scoring methods were not equivalent. When established cut-off scores were used, the proportion of abnormal CDTs were significantly different. Concurrent validity with other common cognitive tests was unsatisfactory. The CDT lacks sufficient sensitivity and specificity for the identification of QD and should not be used alone to screen for possible prodromal stages of dementing illnesses. The association of age, gender and level of education with CDT scores should be taken into account by clinicians using the CDT. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12404654     DOI: 10.1002/gps.747

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  25 in total

1.  Time that tells: critical clock-drawing errors for dementia screening.

Authors:  Mary C Lessig; James M Scanlan; Hamid Nazemi; Soo Borson
Journal:  Int Psychogeriatr       Date:  2007-10-01       Impact factor: 3.878

2.  Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

Authors:  Stefan Smesny; Susan Stein; Ingo Willhardt; Jürgen Lasch; Heinrich Sauer
Journal:  J Neural Transm (Vienna)       Date:  2008-06-27       Impact factor: 3.575

3.  Independent association between preoperative cognitive status and discharge location after cardiac surgery.

Authors:  Mary Beth Harrington; Malissa Kraft; Laura J Grande; James L Rudolph
Journal:  Am J Crit Care       Date:  2011-03       Impact factor: 2.228

4.  A new and short protocol to achieve the early diagnosis of mild cognitive impairment.

Authors:  Sara García; Fernando Cuetos; Antonello Novelli; Carmen Martínez
Journal:  Neurol Sci       Date:  2021-01-13       Impact factor: 3.307

5.  The clock drawing test as a screening tool in mild cognitive impairment and very mild dementia: a new brief method of scoring and normative data in the elderly.

Authors:  Monica Ricci; Martina Pigliautile; Valeria D'Ambrosio; Sara Ercolani; Cinzia Bianchini; Carmelinda Ruggiero; Nicola Vanacore; Patrizia Mecocci
Journal:  Neurol Sci       Date:  2016-02-10       Impact factor: 3.307

6.  Detecting cognitive impairment in individuals at risk for cardiovascular disease: the "Clock-in-the-Box" screening test.

Authors:  Laura J Grande; James L Rudolph; William P Milberg; Colleen E Barber; Regina E McGlinchey
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-30       Impact factor: 3.485

7.  [Diagnostic yield of cognitive tests applied in primary care. Consistency and validity of screening tests].

Authors:  Teófilo Lorente Aznar; Francisco Javier Olivera Pueyo; Sergio Benabarre Ciria; Mariano Rodríguez Torrente; Beatriz Solans Aisa; Ana Carmen Giménez Baratech
Journal:  Aten Primaria       Date:  2009-11-11       Impact factor: 1.137

8.  Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).

Authors:  Oliver Riedel; Jens Klotsche; Annika Spottke; Günther Deuschl; Hans Förstl; Fritz Henn; Isabella Heuser; Wolfgang Oertel; Heinz Reichmann; Peter Riederer; Claudia Trenkwalder; Richard Dodel; Hans-Ulrich Wittchen
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849

9.  The Framingham Heart Study clock drawing performance: normative data from the offspring cohort.

Authors:  Justin A Nyborn; Jayandra J Himali; Alexa S Beiser; Sherral A Devine; Yangchun Du; Edith Kaplan; Maureen K O'Connor; William E Rinn; Helen S Denison; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  Exp Aging Res       Date:  2013       Impact factor: 1.645

10.  Clock drawing performance in cognitively normal elderly.

Authors:  Emily J Hubbard; Veronica Santini; Christiaan G Blankevoort; Karin M Volkers; Melissa S Barrup; Laura Byerly; Christine Chaisson; Angela L Jefferson; Edith Kaplan; Robert C Green; Robert A Stern
Journal:  Arch Clin Neuropsychol       Date:  2008-02-19       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.